Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Peck

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|March 11, 2023
The Use of Artificial Intelligence Guidance for Rheumatic Heart Disease Screening by NovicesDaniel Peck, Joselyn Rwebembera, Doreen Nakagaayi, et al.
Journal of the American Heart Association|April 21, 2021
Hepatic Steatosis in Patients With Single Ventricle and a Fontan CirculationDavid A Katz, Daniel Peck, Adam M Lubert, et al.
Pediatric Blood & Cancer|March 27, 2026
CPX-351 in High-Risk Relapsed Pediatric Acute Leukemia: Real-World Phase 1 Data Establishing the FDA-Approved DoseJonathan D Bender, Lauren Pommert, Lori R Backus, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|March 11, 2023
The Use of Artificial Intelligence Guidance for Rheumatic Heart Disease Screening by NovicesDaniel Peck, Joselyn Rwebembera, Doreen Nakagaayi, et al.
Journal of the American Heart Association|April 21, 2021
Hepatic Steatosis in Patients With Single Ventricle and a Fontan CirculationDavid A Katz, Daniel Peck, Adam M Lubert, et al.
Pediatric Blood & Cancer|March 27, 2026
CPX-351 in High-Risk Relapsed Pediatric Acute Leukemia: Real-World Phase 1 Data Establishing the FDA-Approved DoseJonathan D Bender, Lauren Pommert, Lori R Backus, et al.
Pageof 3